InnoSer is committed to services that include efficacy and safety testing of (immuno-) toxicology of drugs, antibodies, vaccines and antivirals. Our state of the art facilities, for infectious disease diagnostics and the BSL-2 and BSL-3 facilities allow preclinical research with highly pathogenic viruses.
In addition, InnoSer offers the possibility to design customer tailored assays for specific viral detections. For ex vivo purposes InnoSer facilitates anatomical pathology analysis through histopathology and longitudinal tomography scanning of viral disease progression.
InnoSer currently provides services for several pharmaceutical and academic research groups for their infectious diseases and vaccine studies in the state of the art BSL-3 facility.